These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal. Ellims PH Cancer Chemother Pharmacol; 1982 Dec; 10(1):1-6. PubMed ID: 6186411 [TBL] [Abstract][Full Text] [Related]
6. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia. Schmid FA; Hutchison DJ; Otter GM; Stock CC Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin. Newman EM; Lu Y; Kashani-Sabet M; Kesavan V; Scanlon KJ Biochem Pharmacol; 1988 Feb; 37(3):443-7. PubMed ID: 3337743 [TBL] [Abstract][Full Text] [Related]
8. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations. Kim K; Blechman WJ; Riddle VG; Pardee AB Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006 [TBL] [Abstract][Full Text] [Related]
9. Experimental and clinical studies on nucleoside analogs as antitumor agents. Burchenal JH; Currie VE; Dowling MD; Fox JJ; Krakoff IH Ann N Y Acad Sci; 1975 Aug; 255():202-12. PubMed ID: 1059355 [No Abstract] [Full Text] [Related]
10. Therapeutic drug monitoring of antimetabolic cytotoxic drugs. Lennard L Br J Clin Pharmacol; 1999 Feb; 47(2):131-43. PubMed ID: 10190647 [TBL] [Abstract][Full Text] [Related]
16. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. Sohn KJ; Croxford R; Yates Z; Lucock M; Kim YI J Natl Cancer Inst; 2004 Jan; 96(2):134-44. PubMed ID: 14734703 [TBL] [Abstract][Full Text] [Related]
17. Effect of antimetabolites on kinetic behavior of proliferating cultured L1210 leukemia cells. Wilkoff LJ; Wilcox WS; Burdeshaw JA; Dixon GJ; Dulmadge EA J Natl Cancer Inst; 1967 Nov; 39(5):965-75. PubMed ID: 6071005 [No Abstract] [Full Text] [Related]
18. Thymidylate synthase pharmacogenetics. Marsh S Invest New Drugs; 2005 Dec; 23(6):533-7. PubMed ID: 16267625 [TBL] [Abstract][Full Text] [Related]
19. Effect of solcoseryl on antitumour action and acute toxicity of some antineoplastic drugs. Danysz A; Sołtysiak-Pawluczuk D; Czyzewska-Szafran H; Jedrych A; Jastrzebski Z Drugs Exp Clin Res; 1991; 17(2):133-8. PubMed ID: 1864228 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of folate-related drug targets in cancer treatment. Robien K; Boynton A; Ulrich CM Pharmacogenomics; 2005 Oct; 6(7):673-89. PubMed ID: 16207145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]